Food and Drug Administration (FDA) advisers on Thursday recommended updating COVID-19 vaccines to target a circulating strain of the virus, while pushing for newer vaccines that provide longer-lasting protection.
The FDA’s Advisory Committee on Vaccines and Related Biologicals voted unanimously to adjust injections to target a XBB strainas well as eliminate the original strain of the coronavirus from the formulation.
However, the committee did not make a formal recommendation on which specific XBB lineage the updated boosters should target, nor did it make a recommendation on who should receive the vaccines and when. The latter is likely to be left to the Centers for Disease Control and Prevention (CDC), which has its own advisory committee meeting next week.
The recommendation will now be given to the FDA, which is expected to make a final decision soon on which strain of COVID-19 to target. Drugmakers need ample time to produce and distribute the new shots, which are expected to be used starting in September as part of a fall booster campaign.
For more information visit NBCNews.com.
The US authorities are urging the population to apply the reinforcements of the COVID-19 vaccine. To see more from Telemundo, visit